HotSpot Therapeutics, Inc. v. Nurix Therapeutics, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 HOTSPOT THERAPEUTICS, INC., Case No. 22-cv-04109-TSH
Plaintiff, ORDER RE: COUNTERCLAIM
DEFENDANTS’ MOTIONS TO
v. DISMISS AND RELATED
ADMINISTRATIVE MOTIONS TO
NURIX THERAPEUTICS, INC., SEAL Defendant. Re: Dkt. Nos. 24, 25, 28, 29, 36, 37, 38, 39,
40, 41, 42,
13 I. INTRODUCTION Pending before the Court are Plaintiff/Counterclaim Defendant HotSpot Therapeautics, Inc’s (“HotSpot”) Motion to Dismiss Defendant Nurix Therapeutics, Inc.’s (“Nurix”) Counterclaims (ECF No. 25), Counterclaim Defendant Kenneth G. Carson’s Motion to Dismiss Nurix’s Counterclaims (ECF No. 29), and related Administrative Motions to Seal (ECF Nos. 24, 28, 37, 39, 40, and 42). On September 15, 2022, Nurix filed separate Oppositions. ECF Nos. 36, 38. On September 29, 2022, HotSpot and Carson filed separate Replies. ECF Nos. 41, 43. The Court previously found these…